Byooviz Prescribing & Dosing Schedule

Dosage & Administration Drug label Prior authorization Financial assistance Patient education People also ask

Byooviz (ranibizumab-nuna)

Byooviz 0.5 MG in 0.05 ML Injection

NO BOXED WARNING

Dosage & Administration

For ophthalmic intravitreal injection only

* Neovascular (Wet) Age-Related Macular Degeneration (AMD) :
BYOOVIZ 0.5 mg (0.05 mL) is recommended to be administered by intravitreal injection once a month (approximately 28 days).
* Although not as effective, patients may be treated with 3 monthly doses followed by less frequent dosing with regular assessment.
* Although not as effective, patients may also be treated with one dose every 3 months after 4 monthly doses. Patients should be assessed regularly.

* Macular Edema Following Retinal Vein Occlusion (RVO) :
BYOOVIZ 0.5 mg (0.05 mL) is recommended to be administered by intravitreal injection once a month (approximately 28 days).
* Myopic Choroidal Neovascularization (mCNV) :
BYOOVIZ 0.5 mg (0.05 mL) is recommended to be initially administered by intravitreal injection once a month (approximately 28 days) for up to three months. Patients may be retreated if needed.

drug label

Byooviz Prescribing Information

Report Adverse Event

prior authorization

Byooviz Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Jul 26, 2024Arizona - Uniform Prior Authorization Form

Verified: Jul 26, 2024Colorado - Uniform Prior Authorization Form

Verified: Jul 26, 2024Hawaii - Uniform Prior Authorization Form

Verified: Jul 26, 2024Illinois - Uniform Prior Authorization Form

Verified: Jul 26, 2024Indiana - Uniform Prior Authorization Form

Verified: Jul 26, 2024Louisiana - Uniform Prior Authorization Form

Verified: Jul 26, 2024Minnesota - Uniform Prior Authorization Form

Verified: Jul 26, 2024New Hampshire - Uniform Prior Authorization Form

Verified: Jul 26, 2024New Mexico - Uniform Prior Authorization Form

Verified: Jul 26, 2024Oregon - Uniform Prior Authorization Form

Verified: Jul 26, 2024Texas - Uniform Prior Authorization Form

Verified: Jul 07, 2024Washington - Uniform Prior Authorization Form

Verified: Jul 07, 2024Wisconsin - Uniform Prior Authorization Form

Coverage Authorization Request

Coverage Authorization Appeals

Benefits investigation

financial assistance

Byooviz Financial Assistance Options

Copay savings program

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

Biogen Free Drug Program

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and copays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Byooviz Patient Education

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

About Byooviz

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Receiving Treatment

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Byooviz FAQs

How is the dosage of Byooviz ?Byooviz is available in 1 dosages, including 10 mg/ml Injection 0.05 ml

What does Byooviz treat?Byooviz treats Diabetic Retinopathy, Macular Edema and Retinal Vein Occlusion

What is Byooviz made of?Byooviz contains ranibizumab which is a Vascular Endothelial Growth Factor Inhibitor

How Is Byooviz Administered?Byooviz is administered as a Injectable

What Are The Byooviz Mechanism Of Action?Byooviz mechanism of action is Vascular Endothelial Growth Factor Inhibitors

FAQ Data Source

Dosage & Administration

Dosage & Administration

drug label

Byooviz Prescribing Information

prior authorization

Byooviz Prior Authorization Resources

Most recent state uniform prior authorization forms

Benefits investigation

financial assistance

Byooviz Financial Assistance Options

Copay savings program

Foundation programs

patient education

Byooviz Patient Education

Patient toolkit

people also ask

Byooviz FAQs